Skip to main content
BELLUSCURA PLC logo

BELLUSCURA PLC — Investor Relations & Filings

Ticker · BELL ISIN · GB00BD3B8Z11 LEI · 213800BRJQZE56XBPW94 IL Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2025-11-05 Legal Proceedings Report
Country GB United Kingdom
Listing IL BELL

About BELLUSCURA PLC

https://belluscura.com/

Belluscura PLC is a medical device company specializing in the development and commercialization of advanced oxygen enrichment technologies. The company's primary focus is on manufacturing lightweight, portable oxygen concentrators (POCs) designed to improve the quality of life for individuals requiring supplemental oxygen therapy. Its product portfolio is headlined by the FDA-cleared X-PLOR® and the DISCOV-R™ models. These devices utilize proprietary, patented technologies such as ModulAir™ and an Airgonomical™ design to deliver high oxygen output in a compact form factor, offering an alternative to traditional, cumbersome oxygen tanks and promoting user mobility and independence.

Recent filings

Filing Released Lang Actions
Intention to appoint Administrator Update
Legal Proceedings Report Classification · 100% confidence The document is a short regulatory announcement (RNS) from Belluscura PLC regarding the company's intention to appoint an administrator due to insolvency. It does not constitute a full legal proceeding report or a financial report, but rather a corporate update on the company's status. As it is a regulatory announcement regarding corporate status that does not fit into specific categories like M&A or share issues, it is classified as a Regulatory Filing (RNS).
2025-11-05 English
Intention to appoint Administrator
Legal Proceedings Report Classification · 100% confidence The document is a regulatory announcement (RNS) from Belluscura PLC regarding the company's intention to appoint an administrator due to insolvency and the subsequent resignation of its Nominated Adviser. While it discusses significant corporate distress, it does not fit into specific categories like 'Legal Proceedings' (which usually refers to litigation) or 'Delisting' (though it mentions the potential for cancellation of trading, the primary focus is the insolvency/administration process). Given the nature of the announcement as a general regulatory disclosure of material corporate events, 'RNS' is the most appropriate classification.
2025-10-31 English
Replacement Statement re US Subsidiary Update
Legal Proceedings Report Classification · 100% confidence The document is a short regulatory announcement (RNS) regarding a Chapter 7 bankruptcy filing of a subsidiary. It does not constitute a full legal report but rather an update/notification of a legal event. Given the nature of the content (legal proceedings/bankruptcy) and the format (RNS announcement), it fits best under 'Legal Proceedings Report' (LTR).
2025-10-30 English
Statement re US Subsidiary Chapter 7 Update
Legal Proceedings Report Classification · 100% confidence The document is a short regulatory announcement (RNS) regarding a subsidiary filing for Chapter 7 bankruptcy. While it concerns a legal matter, it is a corporate announcement of a significant event rather than a detailed legal proceedings report or a full financial filing. Given the nature of the announcement and the RNS distribution format, it fits best under the general regulatory filing category.
2025-10-30 English
Update re Proposed Fundraise
Regulatory Filings Classification · 98% confidence The document is a regulatory announcement (RNS) from Belluscura plc regarding the foreclosure of assets of its subsidiary, Belluscura LLC, and the potential for a Chapter 7 bankruptcy filing. It discusses financing updates and the impact on the company's contractual arrangements. While it touches on financing, it is primarily a disclosure of a significant corporate event/regulatory update rather than a formal capital raise document or a specific report. Given the nature of the disclosure regarding corporate distress and regulatory notification, 'RNS' is the most appropriate classification.
2025-10-28 English
Directorate Change
Capital/Financing Update Classification · 100% confidence The document is a regulatory announcement (RNS) from Belluscura plc regarding multiple material events: an update on proposed funding/refinancing, significant workforce reductions, and changes to the Board of Directors (resignation of the CEO of the subsidiary and a non-executive director). While it mentions board changes (MANG) and financing updates (CAP), the document is a consolidated regulatory announcement issued via the London Stock Exchange's RNS service. Given the mix of topics and the nature of the RNS format, 'RNS' is the most appropriate classification for this regulatory filing.
2025-09-22 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.